Guangshi Du

Key Laboratory Of Re Generative Medicine In Guizhou Province
Guiyang, 550025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Lactate reprograms PGE2 metabolism via GPR81 inhibits COX2 to relieved psoriasis.

Lactate reprograms PGE2 metabolism via GPR81 inhibits COX2 to relieved psoriasis.

Journal: Scientific reports

Published: December 09, 2025

Targeting chitinase-3-like protein 2 (CHI3L2) suppresses cell proliferation and migration in glioblastoma.

Targeting chitinase-3-like protein 2 (CHI3L2) suppresses cell proliferation and migration in glioblastoma.

Journal: Translational cancer research

Published: October 26, 2025

VSIG2 as a novel immunosuppressive ligand interacts with Nectin-2 to regulate T cell responses.

VSIG2 as a novel immunosuppressive ligand interacts with Nectin-2 to regulate T cell responses.

Journal: Journal of neuroinflammation

Published: October 09, 2025

An antibody targeting an immune checkpoint molecule BTN2A2 enhances anti-tumor immunity.

An antibody targeting an immune checkpoint molecule BTN2A2 enhances anti-tumor immunity.

Journal: Neoplasia (New York, N.Y.)

Published: August 06, 2024

Achromobacter species (sp.) outbreak caused by hospital equipment containing contaminated water: risk factors for infection.

Achromobacter species (sp.) outbreak caused by hospital equipment containing contaminated water: risk factors for infection.

Journal: The Journal of hospital infection

Published: November 16, 2023

Microfluidic-based preparation of artificial antigen-presenting gel droplets for integrated and minimalistic adoptive cell therapy strategies.

Microfluidic-based preparation of artificial antigen-presenting gel droplets for integrated and minimalistic adoptive cell therapy strategies.

Journal: Biofabrication

Published: October 30, 2023

A review for the impacts of circadian disturbance on urological cancers.

A review for the impacts of circadian disturbance on urological cancers.

Journal: Sleep and biological rhythms

Published: June 29, 2023

Microfluidic Chips: Emerging Technologies for Adoptive Cell Immunotherapy.

Microfluidic Chips: Emerging Technologies for Adoptive Cell Immunotherapy.

Journal: Micromachines

Published: March 21, 2023

Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer.

Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer.

Journal: International journal of biological sciences

Published: January 11, 2023

DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis.

DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis.

Journal: Genes & diseases

Published: January 07, 2023

HCG supplement did not accelerate tunica albuginea remodeling to facilitate penile growth.

HCG supplement did not accelerate tunica albuginea remodeling to facilitate penile growth.

Journal: Scientific reports

Published: December 01, 2022

RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to Radiotherapy.

RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to Radiotherapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 06, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026